Banco Bilbao Vizcaya Argentaria SA
3 June 2002
BBVA BANCO FRANCES CAPITALISES DEBTS FOR 209.3
MILLION DOLLARS
> The operation does not involve the additional injection of cash by BBVA nor
will it have any repercussions on the parent company, as the debt provisions
are fully allocated.
BBVA Banco Frances has reached an agreement with the Argentine authorities to
undertake a rights issue for which BBVA will contribute the capitalisation of
209.3 million dollars corresponding to subordinated negotiable bonds in the
possession of BBVA for a sum of 130 million dollars, and of a financial loan
from BBVA for a further 79.3 million dollars.
This capitalisation operation does not involve the additional injection of funds
on the part of BBVA, nor will it have any repercussions on the parent company,
as full provision has been made for both debts on the balance sheet.
Authorisation from the Bank of Spain is a compulsory prerequisite for the
subscription on the part of BBVA of this rights issue. This operation will
improve capital and solvency ratios at a local level.
This information is provided by RNS
The company news service from the London Stock Exchange
PBKDNAK
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.